Introduction to the Policy issues
This chapter serves as a general introduction to the issues raised by the potential adoption of pharmacogenetics in drug development and delivery, including its economic implications, which are examined in greater detail in the rest of the report.
No Supplementary Data
Document Type: Review Article
Publication date: 2009-11-01